These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 9759883)
21. Inhibition of LPS-responses by synthetic peptides derived from LBP associates with the ability of the peptides to block LBP-LPS interaction. Araña Mde J; Vallespi MG; Chinea G; Vallespi GV; Rodriguez-Alonso I; Garay HE; Buurman WA; Reyes O J Endotoxin Res; 2003; 9(5):281-91. PubMed ID: 14577844 [TBL] [Abstract][Full Text] [Related]
22. Preparation and characterization of truncated human lipopolysaccharide-binding protein in Escherichia coli. Kohara J; Tsuneyoshi N; Gauchat JF; Kimoto M; Fukudome K Protein Expr Purif; 2006 Oct; 49(2):276-83. PubMed ID: 16839777 [TBL] [Abstract][Full Text] [Related]
23. Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities. Schumann RR; Lamping N; Hoess A J Immunol; 1997 Dec; 159(11):5599-605. PubMed ID: 9548502 [TBL] [Abstract][Full Text] [Related]
24. Reactivity of murine and human recombinant LPS-binding protein (LBP) within LPS and gram negative bacteria. Lengacher S; Jongeneel CV; Le Roy D; Lee JD; Kravchenko V; Ulevitch RJ; Glauser MP; Heumann D J Inflamm; 1995-1996; 47(4):165-72. PubMed ID: 9144073 [TBL] [Abstract][Full Text] [Related]
25. Identification of single amino acid residues essential for the binding of lipopolysaccharide (LPS) to LPS binding protein (LBP) residues 86-99 by using an Ala-scanning library. Reyes O; Vallespi MG; Garay HE; Cruz LJ; González LJ; Chinea G; Buurman W; Araña MJ J Pept Sci; 2002 Apr; 8(4):144-50. PubMed ID: 11991204 [TBL] [Abstract][Full Text] [Related]
26. Surfactant protein a inhibits lipopolysaccharide-induced immune cell activation by preventing the interaction of lipopolysaccharide with lipopolysaccharide-binding protein. Stamme C; Müller M; Hamann L; Gutsmann T; Seydel U Am J Respir Cell Mol Biol; 2002 Sep; 27(3):353-60. PubMed ID: 12204898 [TBL] [Abstract][Full Text] [Related]
27. Analysis of lipopolysaccharide (LPS)-binding characteristics of serum components using gel filtration of FITC-labeled LPS. de Haas CJ; van Leeuwen HJ; Verhoef J; van Kessel KP; van Strijp JA J Immunol Methods; 2000 Aug; 242(1-2):79-89. PubMed ID: 10986391 [TBL] [Abstract][Full Text] [Related]
28. Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: preferential interaction with particular classes of lipid. Wurfel MM; Wright SD J Immunol; 1997 Apr; 158(8):3925-34. PubMed ID: 9103463 [TBL] [Abstract][Full Text] [Related]
29. Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen. Noursadeghi M; Bickerstaff MC; Gallimore JR; Herbert J; Cohen J; Pepys MB Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14584-9. PubMed ID: 11121061 [TBL] [Abstract][Full Text] [Related]
30. Neutrophil CD14: biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide. Haziot A; Tsuberi BZ; Goyert SM J Immunol; 1993 Jun; 150(12):5556-65. PubMed ID: 7685797 [TBL] [Abstract][Full Text] [Related]
31. Involvement of CD14 and toll-like receptor 4 in the acute phase response of serum amyloid A proteins and serum amyloid P component in the liver after burn injury. Cho K; Pham TN; Crivello SD; Jeong J; Green TL; Greenhalgh DG Shock; 2004 Feb; 21(2):144-50. PubMed ID: 14752288 [TBL] [Abstract][Full Text] [Related]
32. Serum amyloid P component prevents high-density lipoprotein-mediated neutralization of lipopolysaccharide. de Haas CJ; Poppelier MJ; van Kessel KP; van Strijp JA Infect Immun; 2000 Sep; 68(9):4954-60. PubMed ID: 10948110 [TBL] [Abstract][Full Text] [Related]
33. Lipopolysaccharide-binding protein accelerates and augments Escherichia coli phagocytosis by alveolar macrophages. Klein RD; Su GL; Schmidt C; Aminlari A; Steinstraesser L; Alarcon WH; Zhang HY; Wang SC J Surg Res; 2000 Dec; 94(2):159-66. PubMed ID: 11104656 [TBL] [Abstract][Full Text] [Related]
34. Inactivation of endotoxin by human plasma gelsolin. Bucki R; Georges PC; Espinassous Q; Funaki M; Pastore JJ; Chaby R; Janmey PA Biochemistry; 2005 Jul; 44(28):9590-7. PubMed ID: 16008344 [TBL] [Abstract][Full Text] [Related]
35. Lipopolysaccharide-binding protein down-regulates the expression of interleukin-6 by human gingival fibroblast. Ren L; Leung WK; Loo TW; Jin L J Periodontal Res; 2005 Oct; 40(5):407-16. PubMed ID: 16105094 [TBL] [Abstract][Full Text] [Related]
36. Lipopolysaccharide (LPS)-binding synthetic peptides derived from serum amyloid P component neutralize LPS. de Haas CJ; van der Zee R; Benaissa-Trouw B; van Kessel KP; Verhoef J; van Strijp JA Infect Immun; 1999 Jun; 67(6):2790-6. PubMed ID: 10338482 [TBL] [Abstract][Full Text] [Related]
37. Low potency of Chlamydophila LPS to activate human mononuclear cells due to its reduced affinities for CD14 and LPS-binding protein. Tsutsumi-Ishii Y; Shimada K; Daida H; Toman R; Nagaoka I Int Immunol; 2008 Feb; 20(2):199-208. PubMed ID: 18056918 [TBL] [Abstract][Full Text] [Related]
38. Lipopolysaccharide binding protein from normal human plasma purified with high efficiency. Nanbo A; Nishimura H; Nagasawa S Protein Expr Purif; 1997 Jun; 10(1):55-60. PubMed ID: 9179291 [TBL] [Abstract][Full Text] [Related]
39. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS. Sauter KS; Brcic M; Franchini M; Jungi TW Vet Immunol Immunopathol; 2007 Jul; 118(1-2):92-104. PubMed ID: 17559944 [TBL] [Abstract][Full Text] [Related]
40. LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells. Blais DR; Vascotto SG; Griffith M; Altosaar I Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4235-44. PubMed ID: 16249503 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]